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Suicide, this very complex and multicausal human beha-
viour, is related to several psychiatric-medical, psycho-
social and demographic suicide risk factors. Psychological
autopsy studies consistently show that over 90 percent of
suicide victims have at least one (mostly untreated) cur-
rent major mental disorder, most frequently major
depressive episode (56-87%) substance-related disorders
(26-55%) and schizophrenia (6-13%). As suicidal beha-
viour in patients with mood disorders seems to be state-
dependent phenomenon (i.e., it decreases or vanishes
after the clinical recovery), the succesful acute and long-
term treatment of mood disorders is crutial for suicide
prevention [1]. However, depression is freuently underre-
ferred, underdiagnosed and undertreated (and in the case
of unrecognized bipolarity mistreated), and the rate of
adequate antidepressant pharmacotherapy among
depressed suicide victims is less than 20%, which is dis-
turbingly low [2]. The marked decrease in antidepressant
utilization among children and adolescents most recently
in the United States, The Netherlands and Canada coin-
cided with a sharp increase in the rates of completed sui-
cide in this subpopulation [3].
The most important pharmacotherapy-related factors
of suicide in depression are: 1/ lack of treatment,
2/ inadequate treatment, 3/ the first 10-14 days of the
treatment, particularly in the case of insufficient care
and/or lack of co-medication with anxiolytics, 4/ early
termination of the therapy either by the patient or by
the doctor, 5/ lack of the long-term treatment in
chronic or recurrent cases, and 6/ nonresponse and
treament resistance. Most recent findings strongly
suggest that antidepressant monotherapy (unprotected
by mood stabilizers or atypical antipsychotics) can wor-
sen the short-and long-term course of bipolar depres-
sion and increases the risk of suicidal behaviour [4].
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